Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
October 14, 2026
HSV and cancer: What patients should know
Cancer treatments can weaken immunity and trigger herpes simplex reactivation, but patients can take protective steps
A 72-hour checkpoint for CAR T-cell neurotoxicity treatment
From Dr. Emily Liang and the Gauthier Lab, Clinical Research Division
A new clue to resistance in metastatic prostate cancer
From Dr. Steven Blinka, Clinical Research Division and the Hsieh Lab, Human Biology Division
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance
A Nature study reveals that a single transfer RNA (tRNA) helps determine whether prostate cancer remains treatment-sensitive or becomes resistant, opening new avenues in precision oncology
Fred Hutch Cancer Center to lead $15 million national clinical trial initiative for older adults with acute myeloid leukemia
A new five-year funding award led by Fred Hutch physician and stem cell transplant expert Mohamed Sorror, MD, MS, from the Patient-Centered Outcomes Research Institute (PCORI) will support three national randomized trials
Dr. Heather Cheng receives the Marty Lazarus Weiden Family Endowed Chair
Funding will support innovative work to detect, prevent and treat hereditary cancers
Gut microbes that get along: identifying cohesive modules of engraftment
From Dr. Armin Rashidi and colleagues, Clinical Research Division
FDA approves new breast cancer drug based on VIKTORIA-1 study results
New targeted drug brings ‘big change, big benefit,’ per Fred Hutch’s Dr. Sara Hurvitz, who led the study
My cells or yours? Evaluating stem cell transplants for treatment-resistant anaplastic large cell lymphoma
From the Thakar group, Clinical Research Division
CAR-T cell patients have depleted antibody immunity. Vaccination can restore it for some
From the Joshua Hill Lab, Vaccine and Infectious Disease and Clinical Research Divisions
How effective is elranatamab for treating multiple myeloma in the real world?
From Dr. Andrew Portuguese, Clinical Research Division
Oncology Insights with Dr. Petros Grivas - Episode 16
Dr. Marco Mielcarek on making blood and marrow transplants safer and more accessible
Mail-in immune monitoring brings clinical trials closer to home
From the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium
Oncology Insights with Dr. Petros Grivas - Episode 15
Exploring neuro-oncology leadership and innovation with Dr. Vyshak Venur